Skip to main content
OpenTrials
Recruiting

NCT Number: NCT07371000

Early Detection of OAB and Elimination of Negative Impact on Quality of Life

Overactive bladder (OAB) is one of the most common health problems in the adult population. The goal of this project is to improve the awareness of the problem and to correctly refer the targeted persons to a specialist or a doctor. This will be provided by an online screening tool, designed as web platform and mobile application, where the data will be stored in respect to GDPR. People with a positive result from the online screening tool will be offered an examination by a specialist (gynaecologist, urogynaecologist, urologist) involved in the project. The specialist will have access to the results from the online screening tool - he/she will log into the web platform with a view of the participants profile. He/she will perform the diagnosis, confirm or refute the diagnosis and complement it with any further diagnostic tests and set the standard treatment.

Recruiting

Interested in participating?

Request Info

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Brno University Hospital, Brno, Czechia

Loading trial locations.

About this study

Overactive bladder (OAB) is one of the most common health problems in the adult population (15-20% prevalence), with just under half of those affected seeking professional medical help. The goal of this project is to improve the awareness of the problem and to correctly refer the targeted participants to a specialist or a doctor who is knowledgeable about the problem and who will set up an adequate therapy.

A targeted PR campaign will direct those interested in joining the pilot screening project to a website with information about OAB and information about the pilot screening process. The web platform will also guide the user to create a secure user profile to participate in the project, where they will complete validated questionnaires related to OAB, necessary personal and family history data to optimize follow-up diagnosis during the in-person examination with a specialist, and a validated questionnaire measuring quality of life. After completing the online screening tool, the user will be offered a referral to a specialist in the vicinity. Participation in the online screening tool will be conditional on checking the online Consent to Participate box and Consent to Disclose Personal Data in accordance with GDPR.

People with a positive result from the online screening tool will be offered an examination by a specialist (gynaecologist, urogynaecologist, urologist) involved in the project. The specialist will have access to the results from the online screening tool - he/she will log into the web platform with a view of the participant's profile. He/she will perform the diagnosis, confirm or refute the diagnosis and complement it with any further diagnostic tests and set the standard treatment.

The data collected will be used to properly evaluate the pilot project in line with its objectives. An analysis of the problems and risks of the project with regard to the whole pilot screening process and a simplified cost evaluation will also be carried out.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Signed Consent to Participate in the Project and Consent to the Processing of Personal Data (online and paper format)
  • Men and women over 18 years of age with increased urinary frequency (more than 7 times in 24 hours)

Optional inclusion criteria:

  • Nycturia and/or urge incontinence.

Exclusion criteria

  • Unsigned Consent to Participate in the Project and Consent to the Processing of Personal Data.
  • Current treatment of OAB, acute problems, suspicion of another disease causing OAB symptoms (haematuria, suspected bladder cancer, etc.)
  • Inflammation of the lower urinary tract.

Treatment and study plan

Standardized Screening Protocol

Other

After completing the online screening tool (including validated questionnaires), selected participants are offered an appointment with a specialist who will perform a diagnosis, confirm or rule out OAB and set up adequate therapy according to recommended procedures.

Primary outcomes

  1. Pilot testing with 1,000 participants

    Time frame: From enrollment to the end of examination in 3 months

    Pilot testing of the procedure on a sample of 1,000 people who will undergo an online self-diagnostic screening tool and be examined by a urogynecologist/urologist.

  2. Number of participants (completion of anonymous screening test)

    Time frame: from enrollment up to 1 week

    Number of participants who complete anonymous screening test based on three questions reffering to urology health

  3. Percentage of people with suspected OAB who agreed to participate in a follow-up examination with specialist

    Time frame: From enrollment up to 3 months

  4. Percentage of people with a specialist confirmed diagnosis of OAB at the face-to-face visit

    Time frame: Through study completion, an average of 6 months

  5. Percentage of people who attended follow-up examination after 3 months

    Time frame: Through study completion, an average of 9 months

Study contacts

Contact information is provided by the study sponsor or research team.

Kateřina Ondrášková, Msc

CONTACT

[email protected]

604603143

Lucie Mandelová, PhD

CONTACT

[email protected]

Sponsors and collaborators

Lead sponsor

Institute of Health Information and Statistics of the Czech Republic

Other Gov

Collaborators

  • General University Hospital, Prague

Registry information

Official study title

Early Detection of Overactive Bladder and Elimination of Negative Impact on Quality of Life

Important dates

Study start
2025
Primary completion
2026
Study completion
2026
First posted
Jan 27, 2026
Registry last updated
Jan 27, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.